Sensorion S.A.

Sensorion S.A.

SENOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.59B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sensorion S.A.Sensorion S.A.-2--76%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.59 Billion
Enterprise Value$4.58 Billion
Earnings per Share$-1.49
Beta0
Outstanding Shares1,683,338,237

Return

Return on Equity-76.27%ROE
Return on Assets-61.74%
Return on Invested Capital-83.23%

Valuation & Multiples

P/E Ratio-1.99P/E Ratio
PEG-6.79PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue782.97
Enterprise Value to EBIT-62.06
Enterprise Value to Net Income-74
Total Debt to Enterprise0
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Sensorion S.A.

66 employees
CEO: Frédéric Chéreau

Sensorion SA is a clinical-stage biopharmaceutical firm based in Montpellier, France, specializing in the development of therapies for inner ear disorders. Their key initiatives include gene therapy programs: OTOF-GT, designed to restore...

Questions & Answers